Stéphane Bancel, Moderna CEO (Adam Glanzman/Bloomberg via Getty Images)
September 30, 2021 10:20 AM EDTUpdated 10:32 AM
Pharma

Con­tin­u­ing to chart post-Covid path, Mod­er­na will build new sci­ence cen­ter near Mass­a­chu­setts head­quar­ters

Max Gelman

Senior Editor

As Mod­er­na con­tin­ues to bal­loon in­to one of the largest mar­ket caps in the world, the biotech at the fore­front of the Covid-19 vac­cine field …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

A service from the Financial Times